Insiders who reported open-market trades in the last 12 months at the companies Michael Morrissey files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Dana Aftab - $7.70M in EXEL purchases and sales in the last 12 months
Patrick J. Haley - $7.60M in EXEL purchases and sales in the last 12 months
Marshall Fordyce - $7.10M in VERA purchases and sales in the last 12 months
Julie Smith - $4.69M in EXEL purchases and sales in the last 12 months
Michael Morrissey is a corporate insider of Vera Therapeutics, Inc. (VERA). InsiderAlpha holds 13 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Michael Morrissey last file a Form 4?
The most recent primary Form 4 on record is dated 26 May 2026, one of 13 filings going back to 2024.
Michael Morrissey files SEC Form 4 reports at Vera Therapeutics, Inc. (VERA). 13 SEC Form 4 filings on record going back to 2024, most recently on 26 May 2026.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Michael Morrissey.
InsiderAlpha's records for Michael Morrissey go back to 2024: 13 primary Form 4 filings, an average of 4.3 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
